These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 28225830)

  • 21. Selective BCL-X
    Ren Y; Huang SH; Macedo AB; Ward AR; Alberto WDC; Klevorn T; Leyre L; Copertino DC; Mota TM; Chan D; Truong R; Rohwetter T; Zumbo P; Dündar F; Betel D; Kovacs C; Benko E; Bosque A; Jones RB
    J Virol; 2021 Jul; 95(15):e0242520. PubMed ID: 33980597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment.
    Aamer HA; McClure J; Ko D; Maenza J; Collier AC; Coombs RW; Mullins JI; Frenkel LM
    PLoS Pathog; 2020 Aug; 16(8):e1008791. PubMed ID: 32841299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART.
    Wiegand A; Spindler J; Hong FF; Shao W; Cyktor JC; Cillo AR; Halvas EK; Coffin JM; Mellors JW; Kearney MF
    Proc Natl Acad Sci U S A; 2017 May; 114(18):E3659-E3668. PubMed ID: 28416661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved assays to measure and characterize the inducible HIV reservoir.
    Massanella M; Yek C; Lada SM; Nakazawa M; Shefa N; Huang K; Richman DD
    EBioMedicine; 2018 Oct; 36():113-121. PubMed ID: 30316868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing.
    Cho A; Gaebler C; Olveira T; Ramos V; Saad M; Lorenzi JCC; Gazumyan A; Moir S; Caskey M; Chun TW; Nussenzweig MC
    Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35042816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Select host restriction factors are associated with HIV persistence during antiretroviral therapy.
    Abdel-Mohsen M; Wang C; Strain MC; Lada SM; Deng X; Cockerham LR; Pilcher CD; Hecht FM; Liegler T; Richman DD; Deeks SG; Pillai SK
    AIDS; 2015 Feb; 29(4):411-20. PubMed ID: 25602681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
    Chun TW; Carruth L; Finzi D; Shen X; DiGiuseppe JA; Taylor H; Hermankova M; Chadwick K; Margolick J; Quinn TC; Kuo YH; Brookmeyer R; Zeiger MA; Barditch-Crovo P; Siliciano RF
    Nature; 1997 May; 387(6629):183-8. PubMed ID: 9144289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane.
    Wang Z; Gurule EE; Brennan TP; Gerold JM; Kwon KJ; Hosmane NN; Kumar MR; Beg SA; Capoferri AA; Ray SC; Ho YC; Hill AL; Siliciano JD; Siliciano RF
    Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2575-E2584. PubMed ID: 29483265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-molecule techniques to quantify and genetically characterise persistent HIV.
    Wang XQ; Palmer S
    Retrovirology; 2018 Jan; 15(1):3. PubMed ID: 29316955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of the PD-1 axis alone is not sufficient to activate HIV-1 virion production from CD4+ T cells of individuals on suppressive ART.
    Bui JK; Cyktor JC; Fyne E; Campellone S; Mason SW; Mellors JW
    PLoS One; 2019; 14(1):e0211112. PubMed ID: 30682108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling HIV-1 Latency in Primary T Cells Using a Replication-Competent Virus.
    Martins LJ; Bonczkowski P; Spivak AM; De Spiegelaere W; Novis CL; DePaula-Silva AB; Malatinkova E; Trypsteen W; Bosque A; Vanderkerckhove L; Planelles V
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):187-93. PubMed ID: 26171776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy.
    Gandhi RT; Cyktor JC; Bosch RJ; Mar H; Laird GM; Martin A; Collier AC; Riddler SA; Macatangay BJ; Rinaldo CR; Eron JJ; Siliciano JD; McMahon DK; Mellors JW;
    J Infect Dis; 2021 Feb; 223(2):225-233. PubMed ID: 32823274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Approaches to Multi-Parametric HIV-1 Genetics Using Multiple Displacement Amplification: Determining the What, How, and Where of the HIV-1 Reservoir.
    Patro SC; Niyongabo A; Maldarelli F; Kearney MF
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals.
    Wonderlich ER; Subramanian K; Cox B; Wiegand A; Lackman-Smith C; Bale MJ; Stone M; Hoh R; Kearney MF; Maldarelli F; Deeks SG; Busch MP; Ptak RG; Kulpa DA
    PLoS Pathog; 2019 Oct; 15(10):e1008074. PubMed ID: 31609991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immunodeficiency virus type 1-infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified into relevant virologic and immunologic subgroups.
    Dornadula G; Nunnari G; Vanella M; Roman J; Babinchak T; DeSimone J; Stern J; Braffman M; Zhang H; Pomerantz RJ
    J Infect Dis; 2001 Jun; 183(11):1682-7. PubMed ID: 11343220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.
    Persaud D; Pierson T; Ruff C; Finzi D; Chadwick KR; Margolick JB; Ruff A; Hutton N; Ray S; Siliciano RF
    J Clin Invest; 2000 Apr; 105(7):995-1003. PubMed ID: 10749578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring integrated HIV DNA ex vivo and in vitro provides insights about how reservoirs are formed and maintained.
    Pinzone MR; O'Doherty U
    Retrovirology; 2018 Feb; 15(1):22. PubMed ID: 29452580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.
    Spivak AM; Bosque A; Balch AH; Smyth D; Martins L; Planelles V
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5984-91. PubMed ID: 26169416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Galectin-9 Is a Potent Mediator of HIV Transcription and Reactivation.
    Abdel-Mohsen M; Chavez L; Tandon R; Chew GM; Deng X; Danesh A; Keating S; Lanteri M; Samuels ML; Hoh R; Sacha JB; Norris PJ; Niki T; Shikuma CM; Hirashima M; Deeks SG; Ndhlovu LC; Pillai SK
    PLoS Pathog; 2016 Jun; 12(6):e1005677. PubMed ID: 27253379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.
    Wang FX; Xu Y; Sullivan J; Souder E; Argyris EG; Acheampong EA; Fisher J; Sierra M; Thomson MM; Najera R; Frank I; Kulkosky J; Pomerantz RJ; Nunnari G
    J Clin Invest; 2005 Jan; 115(1):128-37. PubMed ID: 15630452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.